Study finds low-income Israelis who recovered from severe or acute infection have averaged 3.3 symptoms per person, while higher-income Israelis average just 1.8 symptoms each
When it comes to avoiding ‘substantial’ disease, boost was 71% effective for Pfizer, 89% for Moderna, but 4th shots give only small edge over 3-dose regimen in preventing infection
Editor David Horovitz on how Qatar allowed Israelis to fulfill soccer dreams; health reporter Nathan Jeffay brings a blitz of optimistic Israeli research
Support granted in exchange for financial reforms; nation hit hard by pandemic and is world’s largest wheat importer, most of which came from Russia and Ukraine
Jewish state ranks 3rd in quantity of vaccine research in the New England Journal of Medicine; across journals, Israeli scientists produced 536 studies, averaging four per week
Editor David Horovitz on today's Knesset agenda and Thursday's live-streamed event, 'Israel’s Judiciary: Reform or Ruin?'; health reporter Nathan Jeffay on the winter 'tripledemic'
The more hesitant people were, the more likely they were to experience side effects, scientists found, after quizzing 750 Israelis on vaccine attitudes and post-shot symptoms
Recent comments